Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Europe’s Biotech Sector Still In Reasonable Shape

Nov 28 2023

• By Kevin Grogan

3d render of Europe map Earth globe

Related Content

‘Anti-VEGFs Have Reached Their Limit:’ EyeBio Targets New Pathway For Eye Therapies

Apr 10 2023

Forbion Will Use New Fund To Rescue Struggling Biotechs

Apr 24 2023

Finance Watch: Gilde Closes Sixth Venture Fund With €740m For Drugs, MedTech

Nov 21 2023

Abivax Confident About Securing Success Stateside

Oct 25 2023

Norway’s Nykode Eyes NASDAQ As Pipeline Advances

Nov 15 2023

UK's T-Therapeutics Raises Almost $60m Despite Tough Funding Environment

Nov 15 2023

Novartis Casts Nets Globally To Snap Up Best Assets

Nov 10 2023

Related Companies

EyeBio

Nouscom AG

VectorY Therapeutics

Nykode Therapeutics AS

Novartis AG

DTx Pharma

Eli Lilly and Company

Additional Topics

Europe Financing Business Strategies Commercial Growth C-Suite Speaks Outlook 2024 Commercial Strategies BioPharmaceutical

More from C-Suite Speaks

More from Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window